J&J beats quarterly sales and profit estimates on cancer drug sales
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson (JNJ) on Tuesday reported first-quarter revenue and profit above Wall Street estimates, driven again by strong sales of its cancer treatments including multiple myeloma medicine …